pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3150b |
Genomic Coordinates | chr8: 95072911 - 95072996 |
Description | Homo sapiens miR-3150b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3150b-3p | ||||||||||||||||||
Sequence | 53| UGAGGAGAUCGUCGAGGUUGG |73 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BTG2 | ||||||||||||||||||||
Synonyms | APRO1, PC3, TIS21 | ||||||||||||||||||||
Description | BTG anti-proliferation factor 2 | ||||||||||||||||||||
Transcript | NM_006763 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BTG2 | |||||||||||||||||||||
3'UTR of BTG2 (miRNA target sites are highlighted) |
>BTG2|NM_006763|3'UTR 1 GCCCTTCCGCCCCCGCCCTGGGCGCCGCCGTGCTCATGCTGCCGTGACAACAGGCCACCACATACCTCAACCTGGGGAAC 81 TGTATTTTTAAATGAAGAGCTATTTATATATATTATTTTTTTTTAAGAAAGGAGGAAAAGAAACCAAAAGTTTTTTTTAA 161 GAAAAAAAATCCTTCAAGGGAGCTGCTTGGAAGTGGCCTCCCCAGGTGCCTTTGGAGAGAACTGTTGCGTGCTTGAGTCT 241 GTGAGCCAGTGTCTGCCTATAGGAGGGGGAGCTGTTAGGGGGTAGACCTAGCCAAGGAGAAGTGGGAGACGTTTGGCTAG 321 CACCCCAGGAAGATGTGAGAGGGAGCAAGCAAGGTTAGCAACTGTGAACAGAGAGGTCGGGATTTGCCCTGGGGGAGGAA 401 GAGAGGCCAAGTTCAGAGCTCTCTGTCTCCCCCAGCCAGACACCTGCATCCCTGGCTCCTCTATTACTCAGGGGCATTCA 481 TGCCTGGACTTAAACAATACTATGTTATCTTTTCTTTTATTTTTCTAATGAGGTCCTGGGCAGAGAGTGAAAAGGCCTCT 561 CCTGATTCCTACTGTCCTAAGCTGCTTTTCTTGAAATCATGACTTGTTTCTAATTCTACCCTCAGGGGCCTGTAGATGTT 641 GCTTTCCAGCCAGGAATCTAAAGCTTTGGGTTTTCTGAGGGGGGGGAGGAGGGAACTGGAGGTTATTGGGGTTAGGATGG 721 AAGGGAACTCTGCACAAAACCTTTGCTTTGCTAGTGCTGCTTTGTGTGTATGTGTGGCAAATAATTTGGGGGTGATTTGC 801 AATGAAATTTTGGGACCCAAAGAGTATCCACTGGGGATGTTTTTTGGCCAAAACTCTTCCTTTTGGAACCACATGAAAGT 881 CTTGATGCTGCTGCCATGATCCCTTTGAGAGGTGGCTCAAAAGCTACAGGGAACTCCAGGTCCTTTATTACTGCCTTCTT 961 TTCAAAAGCACAACTCTCCTCTAACCCTCCCCTCCCCCTTCCCTTCTGGTCGGGTCATAGAGCTACCGTATTTTCTAGGA 1041 CAAGAGTTCTCAGTCACTGTGCAATATGCCCCCTGGGTCCCAGGAGGGTCTGGAGGAAAACTGGCTATCAGAACCTCCTG 1121 ATGCCCTGGTGGGCTTAGGGAACCATCTCTCCTGCTCTCCTTGGGATGATGGCTGGCTAGTCAGCCTTGCATGTATTCCT 1201 TGGCTGAATGGGAGAGTGCCCCATGTTCTGCAAGACTACTTGGTATTCTTGTAGGGCCGACACTAAATAAAAGCCAAACC 1281 TTGGGCACTGTTTTTTCTCCCTGGTGCTCAGAGCACCTGTGGGAAAGGTTGCTGTCTGTCTCAGTACAATCCAAATTTGT 1361 CGTAGACTTGTGCAATATATACTGTTGTGGGTTGGAGAAAAGTGGAAAGCTACACTGGGAAGAAACTCCCTTCCTTCAAT 1441 TTCTCAGTGACATTGATGAGGGGTCCTCAAAAGACCTCGAGTTTCCCAAACCGAATCACCTTAAGAAGGACAGGGCTAGG 1521 GCATTTGGCCAGGATGGCCACCCTCCTGCTGTTGCCCCTTAGTGAGGAATCTTCACCCCACTTCCTCTACCCCCAGGTTC 1601 TCCTCCCCACAGCCAGTCCCCTTTCCTGGATTTCTAAACTGCTCAATTTTGACTCAAAGGTGCTATTTACCAAACACTCT 1681 CCCTACCCATTCCTGCCAGCTCTGCCTCCTTTTCAACTCTCCACATTTTGTATTGCCTTCCCAGACCTGCTTCCAGTCTT 1761 TATTGCTTTAAAGTTCACTTTGGGCCCACAGACCCAAGAGCTAATTTTCTGGTTTGTGGGTTGAAACAAAGCTGTGAATC 1841 ACTGCAGGCTGTGTTCTTGCATCTTGTCTGCAAACAGGTCCCTGCCTTTTTAGAAGCAGCCTCATGGTCTCATGCTTAAT 1921 CTTGTCTCTCTTCTCTTCTTTATGATGTTCACTTTAAAAACAACAAAACCCCTGAGCTGGACTGTTGAGCAGGCCTGTCT 2001 CTCCTATTAAGTAAAAATAAATAGTAGTAGTATGTTTGTAAGCTATTCTGACAGAAAAGACAAAGGTTACTAATTGTATG 2081 ATAGTGTTTTTATATGGAAGAATGTACAGCTTATGGACAAATGTACACCTTTTTGTTACTTTAATAAAAATGTAGTAGGA 2161 TAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_006763 | 3UTR | AAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_006763 | 3UTR | GCUGCUGCCAUGAUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_006763 | 3UTR | UCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_006763 | 3UTR | UGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_006763 | 3UTR | UCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_006763 | 3UTR | UGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_006763 | 3UTR | AUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000290551.4 | 3UTR | UCUAACCCUCCCCUCCCCCUUCCCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
182 hsa-miR-3150b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT066803 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT087964 | TNRC6B | trinucleotide repeat containing 6B | 2 | 4 | ||||||||
MIRT112200 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT115553 | MAZ | MYC associated zinc finger protein | 2 | 2 | ||||||||
MIRT119127 | SPOPL | speckle type BTB/POZ protein like | 2 | 2 | ||||||||
MIRT153910 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT187986 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT240368 | RAB2A | RAB2A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT249675 | SLC39A9 | solute carrier family 39 member 9 | 2 | 4 | ||||||||
MIRT267540 | C1ORF226 | chromosome 1 open reading frame 226 | 2 | 2 | ||||||||
MIRT282540 | SLCO3A1 | solute carrier organic anion transporter family member 3A1 | 2 | 2 | ||||||||
MIRT319703 | UBN2 | ubinuclein 2 | 2 | 2 | ||||||||
MIRT373666 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT390213 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT444379 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT445600 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | 2 | 2 | ||||||||
MIRT445635 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT447181 | PGRMC2 | progesterone receptor membrane component 2 | 2 | 2 | ||||||||
MIRT447212 | APBB2 | amyloid beta precursor protein binding family B member 2 | 2 | 2 | ||||||||
MIRT447247 | IHH | indian hedgehog | 2 | 2 | ||||||||
MIRT447809 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447829 | CTIF | cap binding complex dependent translation initiation factor | 2 | 2 | ||||||||
MIRT449181 | LUC7L3 | LUC7 like 3 pre-mRNA splicing factor | 2 | 2 | ||||||||
MIRT451253 | ZNF444 | zinc finger protein 444 | 2 | 2 | ||||||||
MIRT451378 | C19orf43 | telomerase RNA component interacting RNase | 2 | 2 | ||||||||
MIRT451526 | C16orf58 | chromosome 16 open reading frame 58 | 2 | 2 | ||||||||
MIRT451700 | C1RL | complement C1r subcomponent like | 2 | 2 | ||||||||
MIRT453643 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT454417 | SEPT6 | septin 6 | 2 | 2 | ||||||||
MIRT454636 | FAM83H | family with sequence similarity 83 member H | 2 | 2 | ||||||||
MIRT454889 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT455298 | BCL2L1 | BCL2 like 1 | 2 | 2 | ||||||||
MIRT455521 | C6orf106 | chromosome 6 open reading frame 106 | 2 | 2 | ||||||||
MIRT455937 | SURF6 | surfeit 6 | 2 | 2 | ||||||||
MIRT456133 | SAMD10 | sterile alpha motif domain containing 10 | 2 | 2 | ||||||||
MIRT456325 | ARHGEF2 | Rho/Rac guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT457301 | ZBTB45 | zinc finger and BTB domain containing 45 | 2 | 2 | ||||||||
MIRT457461 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT457533 | ZMAT5 | zinc finger matrin-type 5 | 2 | 2 | ||||||||
MIRT457797 | VWA1 | von Willebrand factor A domain containing 1 | 2 | 2 | ||||||||
MIRT457917 | ZNF212 | zinc finger protein 212 | 2 | 2 | ||||||||
MIRT457936 | LCE1A | late cornified envelope 1A | 2 | 2 | ||||||||
MIRT458914 | DNM2 | dynamin 2 | 2 | 4 | ||||||||
MIRT459075 | WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 2 | 2 | ||||||||
MIRT459484 | CCL11 | C-C motif chemokine ligand 11 | 2 | 2 | ||||||||
MIRT459774 | IDH3A | isocitrate dehydrogenase 3 (NAD(+)) alpha | 2 | 2 | ||||||||
MIRT460317 | SH3RF1 | SH3 domain containing ring finger 1 | 2 | 2 | ||||||||
MIRT460697 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT462049 | HOXC13 | homeobox C13 | 2 | 2 | ||||||||
MIRT462156 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 4 | ||||||||
MIRT463293 | ZFP91 | ZFP91 zinc finger protein | 2 | 2 | ||||||||
MIRT463803 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT463895 | WNT7B | Wnt family member 7B | 2 | 2 | ||||||||
MIRT463942 | WIZ | widely interspaced zinc finger motifs | 2 | 2 | ||||||||
MIRT464660 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 4 | ||||||||
MIRT465664 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT465923 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 4 | ||||||||
MIRT466003 | TMEM189 | transmembrane protein 189 | 2 | 4 | ||||||||
MIRT466824 | STX6 | syntaxin 6 | 2 | 6 | ||||||||
MIRT467652 | SLC7A1 | solute carrier family 7 member 1 | 2 | 2 | ||||||||
MIRT467820 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT468743 | SDC2 | syndecan 2 | 2 | 2 | ||||||||
MIRT468793 | SBK1 | SH3 domain binding kinase 1 | 2 | 4 | ||||||||
MIRT469989 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT471352 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT472016 | NPTXR | neuronal pentraxin receptor | 2 | 2 | ||||||||
MIRT472255 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT473114 | MLXIP | MLX interacting protein | 2 | 2 | ||||||||
MIRT473725 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT474006 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 | ||||||||
MIRT474644 | KLF16 | Kruppel like factor 16 | 2 | 2 | ||||||||
MIRT477420 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT477724 | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 2 | 2 | ||||||||
MIRT479574 | CDC42SE1 | CDC42 small effector 1 | 2 | 2 | ||||||||
MIRT480428 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT480439 | C17orf49 | chromosome 17 open reading frame 49 | 2 | 2 | ||||||||
MIRT480650 | BSCL2 | BSCL2, seipin lipid droplet biogenesis associated | 2 | 2 | ||||||||
MIRT480984 | BBC3 | BCL2 binding component 3 | 2 | 2 | ||||||||
MIRT481061 | BASP1 | brain abundant membrane attached signal protein 1 | 2 | 2 | ||||||||
MIRT481257 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481494 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 2 | 8 | ||||||||
MIRT482034 | AMER1 | APC membrane recruitment protein 1 | 2 | 2 | ||||||||
MIRT482663 | FAM195B | MAPK regulated corepressor interacting protein 1 | 2 | 4 | ||||||||
MIRT482681 | NXN | nucleoredoxin | 2 | 4 | ||||||||
MIRT482710 | XRCC3 | X-ray repair cross complementing 3 | 2 | 2 | ||||||||
MIRT482835 | GLI4 | GLI family zinc finger 4 | 2 | 2 | ||||||||
MIRT483324 | SLC35C2 | solute carrier family 35 member C2 | 2 | 4 | ||||||||
MIRT483410 | SPATA6 | spermatogenesis associated 6 | 2 | 4 | ||||||||
MIRT483591 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT483781 | CASKIN1 | CASK interacting protein 1 | 2 | 4 | ||||||||
MIRT483819 | CYP2W1 | cytochrome P450 family 2 subfamily W member 1 | 2 | 6 | ||||||||
MIRT483845 | UNC5B | unc-5 netrin receptor B | 2 | 4 | ||||||||
MIRT483972 | ZADH2 | zinc binding alcohol dehydrogenase domain containing 2 | 2 | 2 | ||||||||
MIRT484083 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 4 | ||||||||
MIRT484393 | ZNF710 | zinc finger protein 710 | 2 | 4 | ||||||||
MIRT484510 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT484797 | GPRC5A | G protein-coupled receptor class C group 5 member A | 2 | 2 | ||||||||
MIRT484858 | ZNF70 | zinc finger protein 70 | 2 | 4 | ||||||||
MIRT485397 | MRVI1 | murine retrovirus integration site 1 homolog | 2 | 8 | ||||||||
MIRT485614 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | 2 | 4 | ||||||||
MIRT486168 | TLE3 | transducin like enhancer of split 3 | 2 | 2 | ||||||||
MIRT486228 | NLRP2 | NLR family pyrin domain containing 2 | 2 | 2 | ||||||||
MIRT486249 | FASTK | Fas activated serine/threonine kinase | 2 | 2 | ||||||||
MIRT486296 | KBTBD3 | kelch repeat and BTB domain containing 3 | 2 | 2 | ||||||||
MIRT486384 | TIGD5 | tigger transposable element derived 5 | 2 | 2 | ||||||||
MIRT486474 | TSC22D1 | TSC22 domain family member 1 | 2 | 2 | ||||||||
MIRT486567 | SLC38A4 | solute carrier family 38 member 4 | 2 | 2 | ||||||||
MIRT486615 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT487499 | IL1F10 | interleukin 1 family member 10 | 2 | 4 | ||||||||
MIRT487520 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT487929 | KCND1 | potassium voltage-gated channel subfamily D member 1 | 2 | 2 | ||||||||
MIRT488047 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | 2 | 2 | ||||||||
MIRT488063 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | 2 | 2 | ||||||||
MIRT488173 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488326 | AFF2 | AF4/FMR2 family member 2 | 2 | 4 | ||||||||
MIRT488925 | GFRAL | GDNF family receptor alpha like | 2 | 2 | ||||||||
MIRT489288 | RBM8A | RNA binding motif protein 8A | 2 | 8 | ||||||||
MIRT489483 | SLITRK5 | SLIT and NTRK like family member 5 | 2 | 2 | ||||||||
MIRT490460 | PROSER2 | proline and serine rich 2 | 2 | 2 | ||||||||
MIRT490563 | TEX261 | testis expressed 261 | 2 | 4 | ||||||||
MIRT490843 | ADD2 | adducin 2 | 2 | 2 | ||||||||
MIRT491355 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT491455 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT491585 | USB1 | U6 snRNA biogenesis phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT492735 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT493053 | MYO1C | myosin IC | 2 | 4 | ||||||||
MIRT493603 | HMGB3 | high mobility group box 3 | 2 | 6 | ||||||||
MIRT493686 | HAP1 | huntingtin associated protein 1 | 2 | 2 | ||||||||
MIRT493793 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT493881 | FAM73B | mitoguardin 2 | 2 | 4 | ||||||||
MIRT494238 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT494512 | BDNF-AS | BDNF antisense RNA | 2 | 2 | ||||||||
MIRT494717 | ARHGAP31 | Rho GTPase activating protein 31 | 2 | 2 | ||||||||
MIRT494907 | UCP2 | uncoupling protein 2 | 2 | 2 | ||||||||
MIRT498832 | ZNF561 | zinc finger protein 561 | 2 | 2 | ||||||||
MIRT498921 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT498949 | IKBKG | inhibitor of nuclear factor kappa B kinase subunit gamma | 2 | 2 | ||||||||
MIRT499551 | C15orf43 | telomere repeat binding bouquet formation protein 2 | 2 | 2 | ||||||||
MIRT501370 | REXO1 | RNA exonuclease 1 homolog | 2 | 4 | ||||||||
MIRT511910 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT512594 | ZNF783 | zinc finger family member 783 | 2 | 2 | ||||||||
MIRT513339 | CDK2 | cyclin dependent kinase 2 | 2 | 4 | ||||||||
MIRT513729 | PSD3 | pleckstrin and Sec7 domain containing 3 | 2 | 4 | ||||||||
MIRT527702 | IL17REL | interleukin 17 receptor E like | 2 | 2 | ||||||||
MIRT533488 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT533680 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT534167 | SLC8A1 | solute carrier family 8 member A1 | 2 | 2 | ||||||||
MIRT537885 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT538548 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT552014 | RAD18 | RAD18, E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT555336 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | 2 | 4 | ||||||||
MIRT565155 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT568712 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT568824 | TRIM67 | tripartite motif containing 67 | 2 | 2 | ||||||||
MIRT569459 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | 2 | 2 | ||||||||
MIRT569589 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT569619 | ASTN2 | astrotactin 2 | 2 | 2 | ||||||||
MIRT569826 | CRMP1 | collapsin response mediator protein 1 | 2 | 2 | ||||||||
MIRT569985 | TMEM184A | transmembrane protein 184A | 2 | 2 | ||||||||
MIRT570066 | CPNE2 | copine 2 | 2 | 2 | ||||||||
MIRT570540 | RPH3A | rabphilin 3A | 2 | 2 | ||||||||
MIRT570729 | CELSR2 | cadherin EGF LAG seven-pass G-type receptor 2 | 2 | 2 | ||||||||
MIRT570797 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT570898 | METTL21A | methyltransferase like 21A | 2 | 2 | ||||||||
MIRT570944 | CPE | carboxypeptidase E | 2 | 2 | ||||||||
MIRT570964 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571169 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT573015 | RPP25 | ribonuclease P and MRP subunit p25 | 2 | 2 | ||||||||
MIRT573673 | HES6 | hes family bHLH transcription factor 6 | 2 | 2 | ||||||||
MIRT574812 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 2 | ||||||||
MIRT576755 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT618157 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 2 | 2 | ||||||||
MIRT643640 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 2 | 2 | ||||||||
MIRT649084 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT658378 | FAM53C | family with sequence similarity 53 member C | 2 | 2 | ||||||||
MIRT667955 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 2 | 2 | ||||||||
MIRT691696 | FLOT2 | flotillin 2 | 2 | 2 | ||||||||
MIRT697545 | ZBTB44 | zinc finger and BTB domain containing 44 | 2 | 2 | ||||||||
MIRT701530 | NDEL1 | nudE neurodevelopment protein 1 like 1 | 2 | 2 | ||||||||
MIRT705766 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT715222 | NPVF | neuropeptide VF precursor | 2 | 2 | ||||||||
MIRT719548 | CBLB | Cbl proto-oncogene B | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|